1985
DOI: 10.1002/cne.902380205
|View full text |Cite
|
Sign up to set email alerts
|

Central somatostatin systems revealed with monoclonal antibodies

Abstract: The distribution of central neurons displaying somatostatin immunoreactivity was studied using three monoclonal antibodies to cyclic somatostatin. The sensitive ABC immunoperoxidase technique was employed. A large number of positive cell groups including many previously undescribed populations were detected throughout the brain and spinal cord. Telencephalic somatostatin neurons included periglomerular cells in the olfactory bulb, mitral cells in the accessory olfactory bulb, and multipolar cells in the anteri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

10
108
0
1

Year Published

1992
1992
2007
2007

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 261 publications
(119 citation statements)
references
References 98 publications
10
108
0
1
Order By: Relevance
“…These can be distinguished from cholinergic neurons by their smaller size (Di Figlia and Aronin, 1982), even in the ventral striatum (Vincent et al, 1985) and we concentrate our study on the larger neurons. In the dual labeling study, most of the large neurons immunoreactive for NR2D subunits were also immunolabeled with ChAT.…”
Section: Discussionmentioning
confidence: 99%
“…These can be distinguished from cholinergic neurons by their smaller size (Di Figlia and Aronin, 1982), even in the ventral striatum (Vincent et al, 1985) and we concentrate our study on the larger neurons. In the dual labeling study, most of the large neurons immunoreactive for NR2D subunits were also immunolabeled with ChAT.…”
Section: Discussionmentioning
confidence: 99%
“…In the hypothalamus, IDX1/IPF1 is present at a time of active neurogenesis (reviewed in Ref. 20) in regions that generate neurons for several nuclei, including those with the highest number of somatostatin-expressing cells (periventricular, suprachiasmatic, and arcuate nuclei and anterolateral hypothalamus) (43,53).…”
Section: Discussionmentioning
confidence: 99%
“…All secondary antibodies were purchased from commercial sources (Table 1), as well as several primary antibodies: mouse antivasoactive intestinal polypeptide (VIP) and rabbit anti-calretinin (CR) from Biogenesis (Poole, UK); rabbit anti-VIP from Euro-diagnostica (Boldon, UK); rat anti-muscarinic type 2 receptor (M2) and guinea pig anti-substance P receptor (NK1) from Chemicon (Chandlers Ford, UK); rabbit anti-mGluR1a from DiaSorin (Stillwater, MN); mouse antiparvalbumin (PV) from Sigma-Aldrich (Gillingham, UK); and rabbit anti-calbindin (CB-38, lot 5.5), mouse anti-CR, and mouse and rabbit anti-PV from Swant (Bellinzona, Switzerland). Other primary antibodies were kindly provided by the following: Dr. A. Buchan (Medical Research Council Regulatory Peptide Group, Vancouver, British Columbia, Canada), mouse anti-somatostatin (SOM) (Vincent et al, 1985); Dr. K. Tanaka (Niigata University, Niigata, Japan), human anti-glutamic acid decarboxylase (GAD) (Oe et al, 1996); Dr A. Varro (Liverpool University, Liverpool, UK), rabbit anti-procholecystokinin (CCK) (Morino et al, 1994); Dr. K.G. Baimbridge (University of British Columbia, Vancouver, British Columbia, Canada), guinea pig anti-PV ; Dr. J. Polak (Imperial College, London, UK), rabbit antineuropeptide Y (NPY) (Allen et al, 1983); and Dr. B. Gasnier (Centre National de la Recherche Scientifique-Institut de Biologie PhysicoChimique, Paris, France), rabbit anti-vesicular GABA transporter (VI-AAT) (Dumoulin et al, 1999).…”
Section: Methodsmentioning
confidence: 99%